Autonomix Medical (AMIX) Gains from Investment Securities (2023 - 2024)
Autonomix Medical's (AMIX) quarterly Gains from Investment Securities came in at $3.0 million in Q1 2024, up 1413.0% quarter-over-quarter from $200000.0 in Q4 2023.
Powered by 
Analysis
Autonomix Medical (AMIX) Gains from Investment Securities (2023 - 2024) Analysis & Trends
Autonomix Medical (AMIX) has reported Gains from Investment Securities for 2 consecutive years, with $3.0 million the latest figure, recorded in Q1 2024.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $3.0 million in Q1 2024; TTM through Mar 2025 was $3.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.4 million, changed N/A from the prior year.
- Gains from Investment Securities was $3.0 million for Q1 2024 at Autonomix Medical, up from $200000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $3.0 million in Q1 2024 and troughed at $200000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Autonomix Medical | 1.92 Mn | -5.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 239,000.00 |